Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody
Clinical trial NCT03183024 · COMPLETED
Trial details
- NCT number
- NCT03183024
- Sponsor
- Jonathan A. Bernstein, MD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-12
- Primary completion
- 2018-11-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.